PAVmed Inc (PAVMZ)
Company Description
PAVmed Inc. operates as a medical device company in the United States.
The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay.
Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo; and Veris cancer care platform.
The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015.
PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.
| Country | United States |
| IPO Date | Apr 10, 2018 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 39 |
| CEO | Dr. Lishan Aklog M.D. |
Contact Details
Address: 360 Madison Avenue New York, Delaware United States | |
| Website | https://www.pavmed.com |
Stock Details
| Ticker Symbol | PAVMZ |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001624326 |
| CUSIP Number | 70387R122 |
| ISIN Number | US70387R1225 |
| Employer ID | 47-1214177 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dr. Lishan Aklog M.D. | Chairman & Chief Executive Officer |
| Dennis M. McGrath CPA | President & Chief Financial Officer |
| Shaun M. O'Neill M.B.A. | Executive Vice President & Chief Operating Officer |
| Dr. Brian J. deGuzman M.D. | Executive Vice President, Chief Technology & Compliance Officer |
| Dr. Deepika A. Lakhani Ph.D. | Senior Vice President, Chief Regulatory & Quality Officer |
| Dr. Suman M. Verma M.D., Ph.D. | Senior Vice President of Molecular Genetics & Chief Scientific Officer |
| Dr. Victoria T. Lee M.D. | Senior Vice President & Chief Medical Officer |
| Michael Adam Gordon | Executive Vice President, General Counsel & Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 30, 2025 | DEFA14A | Filing |
| Apr 30, 2025 | ARS | Filing |
| Apr 30, 2025 | DEF 14A | Filing |
| Apr 30, 2025 | 25-NSE | Filing |
| Apr 25, 2025 | 8-K | Current Report |
| Apr 21, 2025 | 424B3 | Filing |
| Apr 18, 2025 | PRE 14A | Filing |
| Apr 17, 2025 | 8-K | Current Report |
| Apr 17, 2025 | 424B5 | Filing |
| Apr 11, 2025 | 8-K | Current Report |